Explore by Category
ASCO 2020: KRD vs. VRD for Newly Diagnosed Multiple Myeloma
MYELOMA NEWS - June 01, 2020
The long awaited interim results of efficacy and toxicity from the phase 3 ENDURANCE trial (E1A11) for Newly Diagnosed Multiple Myeloma failed to show a superio... Read More
ASCO 2020: Various Approaches for Smoldering Myeloma
MYELOMA NEWS - May 29, 2020
The treatment of smoldering myeloma is up for debate and has been for years. In one ASCO session, Sagar Lonial, MD of Emory Winship Cancer Institute showed that... Read More
ASCO: An Update on COVID-19 and Cancer Patient Outcomes
MYELOMA NEWS - May 29, 2020
The COVID-19 and Cancer Consortium published new data in The Lancet with the largest data set of cancer patients who had confirmed severe acute r... Read More
Lower COVID Antibody Rates for Cancer Patients
MYELOMA NEWS - May 29, 2020
Cancer patients develop lower levels of antibodies against COVID-19 after having contracted the virus, according to a new paper in Annals of Oncology. ... Read More
ASCO 2020: Are Myeloma Patients Getting the Right Vaccinations?
MYELOMA NEWS - May 26, 2020
Vaccines are the first line of prevention for infectious diseases. This is key for myeloma patients because infection is a major cause of death in myeloma. Mult... Read More
Isatuximab Extends Survival When Used with Carfilzomib and Dexamethasone in Multiple Myeloma
MYELOMA NEWS - May 19, 2020
Adding isatuximab to a combination with carfilzomib and dexamethasone significantly extended remission and survival for relapsed myeloma patients, according to ... Read More
Pandemic Dramatically Impacting Disease Diagnosis and Medical Tests
MYELOMA NEWS - May 14, 2020
“COVID-19 has caused massive disruption to healthcare, one that will reverberate for months and years to come.” — Komodo Health study ... Read More
Blood Based MRD Testing Advances in Multiple Myeloma During COVID-19
MYELOMA NEWS - May 13, 2020
As myeloma patients reduce their visits and regular testing to protect themselves from contracting COVID-19, they are likely to also reduce the number of bone m... Read More
COVID-19 and Cancer Patient Risk: Lessons from New York
MYELOMA NEWS - May 11, 2020
Very few studies have been done on COVID-19 in cancer patients and with over 180,458 cases as of April 10th in New York, it's a location with more data... Read More
Genetics Changes in Myeloma Happen as Early as Precursor Stages
MYELOMA NEWS - May 04, 2020
A recent study by Dana Farber, the Broad Insstitute of MIT, Harvard and Massachusetts General researchers showed that genetic changes that cause or support... Read More
Subcutaneous Daratumumab Receives FDA Approval
MYELOMA NEWS - May 01, 2020
Today the US Food and Drug Administration (FDA) approved DARZALEX FASPRO™ (daratumumab and hyaluronidase-fihj, or a subcutaneous shot of daratumumab) for ... Read More
Chinese Study Finds Cancer Patients at Greater Risk with COVID-19
MYELOMA NEWS - April 29, 2020
Cancer patients were found to be at higher risk for more severe COVID-19 outcomes according to a recent study by Chinese researchers presented at the American A... Read More
A New Imaging Method in Multiple Myeloma Using Daratumumab as a PET/CT Tracer
MYELOMA NEWS - April 29, 2020
Today, myeloma specialists detect the burden of multiple myeloma in patients using blood tests, imaging and bone marrow biopsies. While this is good, better det... Read More
